SG Americas Securities
OLMA icon

SG Americas Securities’s Olema Pharmaceuticals OLMA Stock Holding History

SG Americas Securities’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
+27,885
New +$374K ﹤0.01% 2509
2026
Q1 		– Sell
-69,382
Closed -$1.74M – 3573
2025
Q4 		$1.74M Buy
+69,382
New +$1.23M ﹤0.01% 1620
2025
Q2 		– Sell
-14,193
Closed -$53K – 3404
2025
Q1 		$53K Sell
14,193
-3,282
-19% -$16.5K ﹤0.01% 3235
2024
Q4 		$102K Buy
17,475
+4,419
+34% +$44.1K ﹤0.01% 2728
2024
Q3 		$156K Buy
+13,056
New +$167K ﹤0.01% 2691
2024
Q1 		– Sell
-15,874
Closed -$223K – 3295
2023
Q4 		$223K Buy
15,874
+4,379
+38% +$58.8K ﹤0.01% 2060
2023
Q3 		$142K Buy
+11,495
New +$117K ﹤0.01% 2545
2021
Q4 		– Sell
-14,060
Closed -$387K – 3688
2021
Q3 		$387K Buy
+14,060
New +$380K ﹤0.01% 2723
2021
Q1 		– Sell
-12,300
Closed -$591K – 3483
2020
Q4 		$591K Buy
+12,300
New +$577K ﹤0.01% 1860

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

SG Americas Securities's OLMA Position: Q2 2026 in Review

SG Americas Securities opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 27,885 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #2509 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in OLMA as recently as Q4 2025.

SG Americas Securities first reported a position in OLMA in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.74M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • SG Americas Securities held 27,885 shares of Olema Pharmaceuticals worth $349K as of Q2 2026.
  • Olema Pharmaceuticals was a new SG Americas Securities position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2509 holding.
  • SG Americas Securities first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
  • SG Americas Securities's Olema Pharmaceuticals position peaked at $1.74M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.